Objective: To assess long-term outcome and identify prognostic factors of radiofrequency thermocoagulation (RFTC) following stereoelectroencephalography (SEEG) explorations in particularly complex cases of focal epilepsy. Methods: We retrospectively reviewed the medical charts, video-SEEG recordings, and outcomes for 23 patients (aged 6-53 years) treated with SEEG-guided RFTC, of whom 15 had negative magnetic resonance imaging (MRI) findings, and 10 were considered noneligible for resective surgery after SEEG. Two to 11 RFTCs per patient (mean 5) were produced by applying 40-50 V, 75-110 mA current for 10-60 s on SEEG electrode contacts within the epileptogenic region, which was very close to eloquent cortices in 12 cases. The general features, SEEG findings, and RFTC extent of the patients were analyzed to extract potential preoperative predictors of post-RFTC seizure outcomes. Results: After a mean follow-up of 32 months (range 2-119 months), eight patients experienced a ≥50% decrease of seizure frequency after RFTC (R+, 34.8%), of whom one had a sustained seizure freedom and 15 patients did not benefit from RFTC (RÀ, 65.2%). The presence of an MRI lesion was the only significant predictor of a positive outcome, whereas location of epilepsy, extent of interictal epileptiform discharges (IEDs) and of the seizure onset zone, induction of seizures by electrical stimulation, as well as the ratio of the coagulated sites did not show a significant correlation to the RFTC response. However, (sub-)continuous IEDs were more frequently found in R+ than in RÀ patients, thus suggesting that this EEG marker of the epileptogenic tissue might predict a positive outcome even in patients without obvious MRI lesion. Significance: Our study confirms that RFTC, although less effective than resective surgery, can be a reasonable therapeutic option in complex cases where anatomic constraints make impossible any cortical resection. Further prospective studies are needed to better define RFTC indications and to optimize its methodology.
Despite the increasing use of noninvasive tests in the presurgical evaluation of patients with refractory focal epilepsies, invasive electroencephalography (EEG) recordings remain necessary in a number of patients, especially those without obvious lesion on magnetic resonance imaging (MRI). 1 One of the methods used for invasive exploration is stereo-EEG (SEEG), which consists of the stereotactic implantation of intracerebral electrodes to identify the cortical areas from where seizures originate and where they rapidly propagate in order to perform a tailored cortical resection. 2 Of interest, stereotactic radiofrequency thermocoagulation (RFTC) can be applied at the end of the SEEG investigation, so that SEEG appears to be not only a diagnostic procedure, but also a possible therapeutic option in patients for whom conventional resective surgery cannot be proposed. 3 RFTC was developed >20 years ago, mainly to produce lesions in the amygdala and hippocampus in cases of mesial temporal lobe epilepsy (MTLE), with outcomes that proved to be less favorable than, or similar to, those of standard surgical resective procedures. [4] [5] [6] [7] [8] [9] [10] [11] Following a successful case report of RFTC of the mesial premotor cortex in a patients with nonlesional epilepsy studied by SEEG, 12 the method has been reassessed and applied in etiologies other than hippocampal sclerosis and in extratemporal epilepsies, including MRI-positive and MRI-negative cases. 3, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The feasibility and safety of RFTC has been demonstrated, 3, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] and outcomes appeared more favorable in patients with malformations of the cortical development (MCDs), especially focal cortical dysplasia (FCD) 14, 15, 18, 20, [22] [23] [24] and nodular heterotopia-related epilepsy. 16, 17, 19, 22, 23 Overall, however, SEEG-guided RFTC remains a palliative treatment in most patients, 14, 18, 19, [22] [23] [24] and further studies are needed to better define the indications and to improve the methodology of RFTC technique.
Consequently, we assessed the outcomes of patients treated with SEEG-guided RFTC at our institution to identify SEEG and RFTC variables that could have prognostic significance. Herein we report the results of this study.
Methods

Patient selection
We retrospectively reviewed the medical charts and video-SEEG recordings of 23 consecutive patients in whom RFTC was performed. These patients were selected from a database of 249 SEEG explorations performed between 2000 and 2014, since the first RFTC procedure was done in 2000.
In all cases, presurgical noninvasive investigation included continuous video-EEG recordings and high-resolution MRI. Some patients also underwent functional neuroimaging. Because the data obtained after this first presurgical evaluation phase were not sufficiently concordant for reliable localization of the epileptogenic zone, video-SEEG recordings of spontaneous seizures were undertaken according to the methodology developed by our group. 26 
Patients' characteristics
There were 13 male and 10 female patients, aged from 6 to 53 years (see Table 1 ). The epilepsy started from 3 to 44 years before SEEG procedure. In all patients, the seizure frequency ranged from several per month to multiple per day. MRI findings were negative in 15 cases, and demonstrated FCD in 5 cases, multiple bilateral periventricular nodular heterotopias (PVNHs) in one case, and poststroke perisylvian atrophy in two cases. 18 Fluorodeoxyglucose positron emission tomography (PET) was done in 13 patients, interictal single-photon emission tomography (SPECT) in 4, ictal SPECT in 2, and functional MRI (fMRI) for language lateralization in 5. Three patients had undergone surgery previously (P8, P9, and P18) without longlasting significant improvement. Five patients had already undergone a first intracranial EEG investigation (P5, P8, P9, P14, and P22), of whom two (P5 and P22) had been unsuccessfully treated with SEEG-guided RFTC; therefore, here we consider the results of the second RFTC performed at our institution.
Implantation of SEEG electrodes
The number and placement of intracerebral electrodes were defined according to the prior hypothesis regarding the localization of the epileptogenic tissue, based on seizure semiology and on the results of the noninvasive investigations as described by Kahane et al. 26 Preoperative targeting was performed using three-dimensional (3D) T1 brain MRI computed with a stereotactic software (VoximR, IVS solution, Germany), and stereotactic and stereoscopic digitalized arteriography was done to determine avascular trajectories of the electrodes. Insertion of the electrodes (DIXI Microtechniques, Besanc ßon, France; diameter of 0.8 mm; 10-18 contacts, 2 mm length, 1.5 mm apart) was guided by a robotic arm (Neuromate, ISS, France) that was connected to the Talairach stereotactic frame and driven by the stereotactic software.
Seven to 17 (mean 13) multicontact semi-rigid intracerebral electrodes were implanted per patient (see Table 1 ). Nine patients received a bilateral electrode implantation, with a left hemispheric predominance in five cases, a right hemispheric predominance in three cases, and an equal number of depth electrodes in each hemisphere in one case. In 14 patients (P10-P23), electrode contacts were directly visualized on postimplantation MRI. In the remaining nine were not accompanied by any SEEG changes, although a continuous spiking activity was recorded over the posterior part of the right first temporal gyrus). 27 ; in addition, the location of the electrode contacts was assessed either by superimposing frontal and lateral skull radiography on frontal and parasagittal MRI slices or by a computer-assisted matching of postimplantation CT-scan with a preimplantation 3D MRI.
SEEG recordings and stimulation
Intracerebral recordings were conducted extraoperatively in subchronic conditions (1-3 weeks) with reduced medication using an audio-video-EEG monitoring system (Micromed S.p.A, Mogliano Veneto, Italy) that allowed simultaneous recording of up to 128 contacts, with a sampling rate of either 256 or 512 Hz, and an acquisition bandpass filter between 0.1 and 90 Hz or between 0.1 and 200 Hz, respectively, depending on amplifier capacities at the date of recordings. Data were acquired using a referential montage, with a reference electrode chosen in the white matter.
Depth EEG activity was displayed between contiguous contacts at different levels along the axis of each electrode, and interictal and ictal analysis of SEEG traces was done visually. The seizure-onset zone (SOZ) was visually defined as the region exhibiting the first clear SEEG change that occurred prior to the clinical onset of the seizure. SEEG ictal onsets were considered relevant when they showed a low-voltage fast activity in the beta and gamma bands, 28, 29 or a recruiting and periodic fast discharge of spikes. 30, 31 Interictal epileptiform discharges (IEDs) were considered relevant when they consisted of spikes, polyspikes, spike-and-wave, or polyspike-andwave complexes.
Electrical stimulations (ES) were performed for a few days during 1-3 h sessions, according to our routine procedure. 32 The aim was to reproduce part or the totality of the ictal clinical symptomatology, and to localize functionally eloquent areas that had to be spared during surgery. Bipolar ES were performed at 1 Hz (pulse width: 1 msec; ES duration: 40 s) and 50 Hz (pulse width: 1 msec; ES duration: 5 s), applied between contiguous contacts at various levels of the electrode axis, with stepwise increasing intensities up to 3 mA and until clinical subjective or objective responses or afterdischarges were obtained. Bipolar stimuli were delivered using a constant current rectangular pulse generator designed for a safe diagnostic stimulation of the human brain (Micromed S.p.A) and according to parameters proven to produce no structural damage. 33 Electrically elicited seizures (EES) were considered relevant when they proved clinically identical to the seizures recorded spontaneously. 32, 34, 35 Following SEEG results, RFTC was offered: (1) to patients who were considered not eligible for resective surgery (palliative treatment), (2) to patients who were considered eligible only for a palliative resective surgery (alternative treatment), (3) to patients eligible for a resective surgery and in whom the epileptogenic zone seemed very focal (optional treatment).
Eleven patients had a right-sided, and 12 a left-sided (nondominant for language in 2) focal epilepsy ( Table 1) . The epilepsy was unilobar in 20 cases (insular, 7; frontal, 6; temporal, 4; parietal, 3) and multilobar in three cases (temporoinsular, one; temporooccipital, one; temporalparietooccipital, one). Eight patients were considered potentially treatable by a curative resective surgery, five patients were considered treatable by a palliative resective surgery (involvement of eloquent cortex in four, insufficient definition of the SOZ in one), and 10 patients were considered nonoperable (involvement of eloquent cortex in seven, bilateral SOZ in one, undefined SOZ in two).
RFTC procedure
Overall, 2-11 RFTCs (mean 5) were generated per patient. In 21 cases, RFTC was applied within the SOZ, provided that these contacts were not located in a functionally eloquent area as evaluated by ES, and provided that vascular structures did not lie within the predictable volume of thermolesion. In 12 of the 21 cases, however, RFTC procedures were very close to language (n = 8) or sensorimotor areas (n = 4) (see Table 1 ). In the remaining two patients in whom the SOZ could not be defined because spontaneous seizures were either not recorded (P2) or did not reveal any SEEG changes (P18), the site of RFTC was guided by ES results and IED location, and RFTC was applied in the amygdala and temporopolar region in one case (P2) and in the posterior part of the superotemporal gyrus in the other (P18).
Thermolesions were performed without anesthesia using a radiofrequency generator system (up to 2008: Radionics Medical Products, Burlington, MA, U.S.A.; since 2009: Inomed Medizintechnik GmbH, Emmendingen, Germany). The application of a 40-50 V, 75-110 mA current for 10-60 s (mostly 30 s) between two adjacent contacts of the selected electrodes created a local temperature of about 80°C. As a result, a lesion including the two electrode contacts and the intercontact spacing was produced, having an approximate size of 5-7 mm in diameter. 3, 14, 15, 25 In some patients, two or three successive RFTC procedures were done if the impedances of the contacts used for bipolar RFTC did not decrease significantly after RFTC (meaning that a coagulation necrotic lesion was still not completely obtained). SEEG recordings were performed before and after the RFTC procedure to evaluate how interictal epileptiform activity was influenced by RFTC. SEEG electrodes were usually removed 24 h after RFTC, and the patient was discharged from hospital a few days after.
Post-RFTC outcome
Post-RFTC outcome was usually evaluated at 1, 3, and 6 months, and then once a year. When resective surgery was subsequently performed, the day before surgery was considered the last post-RFTC follow-up. Possible adverse events were noticed, and the rate of seizure frequency reduction was evaluated with respect to the pre-RFTC period. Patients who exhibited a seizure frequency reduction of at least 50% at the last post-RFTC visit were considered as responders to RFTC (R+ group), whereas those who exhibited <50% of seizure reduction were considered as not responders (RÀ group). Post-RFTC brain MRI was done approximately at 3 or 6 months after RFTC to confirm the anatomic localization of the thermolesions, or preoperatively for those of patients who were subsequently operated on after RFTC.
When resective surgery was done, patients were followed up at 3 and 6 months, and then once a year. Final postoperative follow-up was evaluated at the last follow-up visit, according to Engel's classification system. 36 
Illustrative case
P19 illustrates the complete course of a patient. This 22-year-old right-handed man had daily drug-resistant seizures characterized by a painful tingling sensation in the left hand, sometimes followed by a loss of contact, bilateral dystonic posturing, and gestural automatisms. MRI was negative, and the 18-FDG-PET revealed a right insuloorbital hypometabolism. Scalp EEG showed interictally asynchronous bitemporal spikes, and suggested ictally an initial right temporal lobe involvement with a secondary spread to left temporal lobe. The SEEG study (Fig. 1) was focused on the right insular cortex, explored by seven electrodes, with additional electrodes sampling the right temporal lobe (n = 3), the right frontal lobe (n = 3), the left insular cortex (n = 2), and the left temporal lobe (n = 1). SEEG activity Figure 1 . SEEG study of patient 19 . See text for explanation of the case. Letters refer to the electrodes that sampled the right insular cortex. OF, orbitofrontal cortex; DL, dorsolateral frontal cortex; OP, suprasylvian opercular cortex; DL, dorsolateral frontal cortex; MT, mesiotemporal structures; T1, first temporal gyrus; T2, second temporal gyrus; RFTC, radiofrequency thermocoagulation. Interictal spikes and spike-and-waves are continuously recorded over a few contacts of electrode S (contacts 4-5-6) and Y (contacts [8] [9] that are located in the superior part of the anterior long gyrus of the right insula. Ictal discharges start at the same location, and are initiated by repetitive burst of polyspikes followed by low voltage fast activity. Note the complete disappearance of spiking activity after the nine RFTC applied over the contacts S3-S4-S5-S6 and Y6-Y7-Y8-Y9-Y10. Epilepsia ILAE showed (sub)continuous interictal epileptiform discharges (SCIEDs) within the superior part of the anterior long gyrus of the right insula. Ictal discharges started at the same location. Nine radiofrequency thermocoagulations were performed over the posterosuperior insula ( Fig. 2A) , which suppressed SCIEDs and rendered the patient seizure-free for 2 months. Seizures relapsed and the patient was operated on 2 months after because of insufficient improvement (30% seizure reduction). The right anterior long insular gyrus was removed (Fig. 2B) 
Data analysis
The general features, SEEG findings, and RFTC extent of the 23 patients were reviewed to extract potential predictors of seizure outcome after RFTC.
The anatomic extent of IEDs during SEEG was evaluated by the number of electrode contacts exhibiting IEDs. IEDs were classified as focal (i.e., restricted to a few contacts of one or two close intracerebral electrodes exploring the same small anatomic area), regional (i.e., sublobar but involving a larger number of electrode contacts exploring distinct anatomical areas), or extended (i.e., lobar or multilobar). Attention was also paid to repetitive continuous or subcontinuous IEDs (subsequently referred to as (sub)continuous IEDs, SCIEDs) that have been assumed a putative marker of the extent of the epileptogenic (dysplastic) tissue. 37, 38 The anatomic extent of the SOZ was evaluated by the number of electrode contacts exhibiting the relevant SEEGonset patterns (see Methods). If different seizure-onset patterns were recorded, all the contacts involved at seizure onset, whatever the seizures, were included in the SOZ. The SOZ was classified as focal, regional, or extended using the same criteria as those used for IEDs classification.
The presence or absence of EES was observed and, if appropriate, the number of contacts from where seizures were electrically induced was evaluated. Whether these A B contacts were located within the SOZ, the irritative zone (IEDs), or outside these areas was also studied. The anatomic extent of RFTC was evaluated by the number of electrode contacts that were coagulated. The percentage of RFTC applied at IEDs sites, SOZ sites, and EES sites was calculated to search for any influence of the sites and extent of RFTC on seizure outcome.
All relevant data were compared between R+ and RÀ patients using Fisher's exact test or the Mann-Whitney test, where appropriate. Significance was set at p ≤ 0.05.
Results
Outcome
Seizure outcome
Post-RFTC follow-up ranged from 2 to 119 months (mean 32.1 months) ( Table 1) . Four of the nonresponders had a short (<6 months) post-RFTC follow-up because they were eligible for resective surgery (P3, P10, P13, and P19). Eight patients initially became seizure-free after RFTC, of whom seven relapsed after 2-6 months. Overall, at the last follow-up visit, one patient remained seizurefree (for 84 months), 7 patients experienced a ≥50% decrease of seizure frequency, 3 patients experienced a <50% decrease of seizure frequency, and 12 patients did not show any seizure frequency changes. None of the patients, whether or not they initially responded, demonstrated any further improvement. Thus, 8 patients were considered to respond to RFTC (R+, 34.8%), and 15 patients did not benefit from RFTC (RÀ, 65.2%). Of interest, 2 of the 8 patients who were considered treatable by resective surgery did not undergo surgery because of sufficient improvement (P1 and P4), and 6 of the 10 patients who were considered nonoperable, benefited from RFTC (P6, P15, P17, P18, P20, and P21), of whom 2 had a ≥80% decrease of their seizure frequency.
Morbidity
Three patients experienced a neurologic deficit after RFTC that remained permanent in one (P20, right thumb hypoesthesia after left RFTC of M1), and resolved in a few days in the others (P14, left third and fourth fingers paresis after right RFTC of M1; P19, dysgeusia after right RFTC of the posterosuperior insula). In another patient (P15), an intraventicular bleeding associated with 1 week of headaches occurred after RFTC of a right posterior PVNH. The patient fully recovered without any sequelae. In two additional patients, a transient increase of habitual seizures (P10), or the occurrence of a new seizure type (P21) were observed after right frontoopercular RFTC and left insular RFTC, respectively. It spontaneously resolved within a few days in the first case, and 24 h after steroids administration in the second case. One patient (P4) in whom RFTC was applied in the right insular lobe presented a right temporal hematoma after the removal of SEEG electrodes, which was evacuated without sequelae. This hematoma was considered unrelated to the RFTC procedure. One patient (P2) died by suicide 6 months after RFTC, but this event was not considered related to the procedure, since seizure frequency remained unchanged and the patient also had bipolar disorder. One patient (P5) died of sudden unexpected death in epilepsy (SUDEP) 2 years after an ineffective RFTC.
Resective surgery
Nine of the 22 patients in whom seizures persisted or recurred after RFTC, of whom all were in the RÀ group, were subsequently operated on. Four were Engel's class I, one was class III, and 4 were class IV. Surgery was considered curative in five (of whom three were class I), and palliative in four (of whom one was class I) because of anatomic constraints. Outcome did not show any obvious correlation with the presence or absence of an initial seizure-free period post-RFTC.
General features and outcome
The presence of a lesion on MRI was highly predictive of a positive outcome, since 6 (75%) of the 8 patients with a positive MRI responded to RFTC, as compared with only 2 of the 15 patients (13.3%) with a negative MRI (p = 0.006) (Table 3) . Conversely, RFTC responses did not show any difference depending on the location of epilepsy. An initial seizure-free period was found more frequently in R+ (50%) than in RÀ (26.7%), but the difference was not statistically significant.
SEEG findings and outcomes
IEDs were recorded in all the 23 patients, at a mean number of 11.6 AE 8.4 sites per patient (Tables 2 and 3 ). They were focal in eight cases, regional in six cases, and extended in nine cases. Neither the number of IEDs sites nor their extent differed significantly between R+ and RÀ patients. SCIEDs were observed in 14 cases, always in association with other IEDs. They were found in both MRI-negative (n = 7) and MRI-positive cases, including FCD (n = 4), post-stroke atrophy (n = 2), and PVNH (n = 1). It is notable that all but one R+ patients (87.5%) exhibited such a (sub)-continuous pattern as compared with seven of the RÀ patients (46.7%), and the difference almost reached statistical significance (p = 0.09). Altogether, IEDs were suppressed after RFTC in 30.4% of patients, with a rate that was similar in R+ (25%) and RÀ (33.3%) patients.
In 21 patients, 2 to >20 spontaneous habitual seizures were recorded. The SOZ proved to be focal in 16 cases and extended in 5 (including a bilateral case, P15), without any difference between R+ and RÀ patients. The extent of the SOZ as evaluated by the mean number of SEEG sites involved at seizure onset did not show any difference between R+ and RÀ patients. (electrode no.)
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RFTC sites and outcomes
A total number of 112 RFTCs were applied in the 23 patients (4.9 AE 2.6 per patient), without significant difference between R+ (n = 38, 4.7 AE 2.2 per patient) and RÀ (n = 74, 4.9 AE 2.8 per patient) patients (Table 2 and 3) .
RFTCs were applied at 76 of the 266 IED sites (n = 23 patients, mean per patient: 3.4 AE 2.3), 54 of the 94 SCIED sites (n = 14 patients, mean per patient: 3.9 AE 1.9), 81 of the 197 SOZ sites (n = 21 patients, mean per patient: 3.9 AE 2.0), and 32 of the 68 EES sites (n = 14 patients, mean per patient: 2.3 AE 1.7). The mean ratio of RFTC applied at IED sites, SCIED sites, SOZ sites, and EES sites did not show any statistical difference between R+ and RÀ patients.
Discussion
During the last decade, SEEG-guided RFTC has been considered as a possible therapeutic option not only for patients not eligible for resective surgery, but also as a first step in patients who proved to be candidates for resective surgery. 3, 14, 15, 19, 20, [22] [23] [24] In the two largest published series, 25 (28%) of 89 patients had significant improvement 19 and 78 (48%) of 162 patients experienced a ≥50% reduction of seizure frequency 24 after RFTC. Seizure freedom was achieved in 18% (16/89) and 7% (11/ 162) of the patients, respectively. 19, 24 The procedure appeared to be safe, showing transient postprocedure side effects in 2.4% (4/162) 24 and permanent neurologic deficits in 2.2% (2/89) and 1.2% (2/162) of the patients, respectively. 19, 24 Our smaller series confirms in part these findings, although RFTC was conducted in a cohort of particularly complex cases, of whom 15 (65.2%) of 23 had a negative MRI, 6 (26.1%) of 23 had previously undergone a SEEG study and/or a surgical resection, and 11 (47.8%) of 23 had an epileptogenic area encompassing eloquent cortices. Eight (34.8%) of our 23 patients experienced ≥50% reduction of seizure frequency, including 6 (60%) of the 10 patients who were eventually not considered operable at the end of the SEEG study. This is in line with two larger previous studies showing that 41% 19 to 49% 14, 15 of patients in whom surgery was excluded benefited from RFTC. Still, two of our eight patients considered good candidates for curative surgery were sufficiently improved to defer surgery, meaning that a small subset of patients may avoid open surgery, as already reported. 14, 19, 24 However, only one (4.3%) of our 23 patients experienced a sustained seizure freedom, which is closer to the results (2.4% in the earlier and 7% in the most recent study) of Lyon group, 14, 15, 24 but compares unfavorably with those of Cossu et al. 19 This discrepancy is partly explained by the unusually high number of nodular heterotopias in the series of Cossu et al., which accounted for half of the seizure-free cases. 19 Another explanation might be the relatively high number of RFTC applied per patient in the series of Cossu et al. 19 (mean 10.6, range 1-31), which indeed was different from that in our study (mean 5, range 2-11), but not from the one of Catenoix et al.
14 (mean 12, range 2-31). The low number of RFTC sites in our study may find its explanation (1) in the high number of patients in whom the epileptic zone lied in functional areas (some contacts were discarded from the procedure on the basis of ES) and (2) in the high number of patients with an insuloopercular epileptic zone (some contacts were discarded from the procedure because of vascular constraints). Altogether, these data emphasize the need to identify potential predictors of favorable outcome after RFTC, which was one of the goals of our study.
In previous studies, the main predictors of good outcome were the presence of MCDs 14, 15 or nodular heterotopias, 19 and the number of intralesional RFTC sites. 19 More recently, the occipital location of the RFTC target was associated with a better prognosis as well. 24 *** We confirmed, as already reported, 14, 18, 19, 22, 23 that a positive MRI was a strong predictor of favorable outcome after RFTC. This is not surprising, since one of the main limitation of SEEG, and consequently of RFTC, is the unexplored gray matter. Thus the chance of capturing at least part of the SOZ is higher when a lesion is present, especially when the lesion is intrinsically epileptogenic. All six of our patients with an MCD seen on MRI exhibited a seizure frequency reduction, with four of them considered responders, but none exhibited a sustained seizure freedom. The Lyon group has suggested that enhancing the number of RFTC sites (i.e. not only the intralesional contacts exhibiting the low-voltage fast activity but also where such activity is present outside the visible lesion, and in some cases, on SOZ marked by high-frequency spiking) for delineating the epileptogenic area resulted in long-lasting seizure freedom in 6 (43%) of 14 patients with MCD. 20 The benefit-risks ratio was good, and such a strategy could be an option in large-sized lesions for which resective surgery seems a priori risky, as in the one near to eloquent cortex. More recently, the same group even considered the SEEG-guided RFTC a major therapeutic option in patients with large epileptic network, with multifocal ictal onsets inaccessible to resective surgery. 24 Multiple lesions performed within such a network could possibly lead to its functional disruption and as a result, to a significant seizure reduction. 24 Despite careful analysis of RFTC sites with respect to SEEG findings, we failed to clearly identify other predictive factors of RFTC, possibly due to the small size and heterogeneity of the studied population. In particular, neither the extent of the seizure onset and irritative zones nor the number of RFTCs applied within these areas showed any correlation with RFTC outcome. Of interest, however, we found that the pre-RFTC study of SCIEDs could be a predictor of the responding patients, with a difference between R+ and RÀ patients that almost reached statistical significance. This particular interictal SEEG pattern is probably a good marker of the underlying lesional cortex, even in MRI-negative patients, and larger studies are needed to confirm its potential relevance in the RFTC field. On the other hand and in accordance with Catenoix et al., 14 the post-RFTC IED suppression did not influence the long-term outcome. There could be three reasons for this finding: (1) the observation period (24 h) that could be too short to evaluate the definite epileptogenic network changes, which is corroborated by the lack of predictive value of an initial seizure-free period for the long-term outcome 14 ; (2) the suppression of IEDs does not necessarily mean that the epileptogenic brain tissue has been fully destroyed-other interictal markers of epileptogenicity, that is, high-frequency oscillations (HFOs), do not necessarily co-occur with spikes and have been shown to be more specific for the SOZ, 39 and the relevance of HFOs as a marker of the sites to be coagulated could be further studied; (3) an SEEG study provides a weak spatial coverage (i.e., unexplored gray matter areas), so that the post-RFTC suppression of IEDs does not reliably indicate whether the whole epileptogenic network has been fully inactivated. Yet, the RFTC procedure may create a lesion that a lesion not entirely encompassing the underlying pathologic substrate, as demonstrated in a recent welldocumented case report. 40 This spatial limitation is also highlighted in our series by the absence of any relationship between post-RFTC outcome and IED sites, SCIEDs sites, SOZ sites, and EES sites.
Three of our patients experienced after RFTC a minor neurologic deficit that remained permanent in one (4.3%). Other transient side effects linked directly to the procedure occurred in three additional cases, including one intraventricular bleeding and two post-RFTC seizure changes. Although infrequent, such adverse events emphasize that RFTC remains a destructive procedure thus necessitating a careful evaluation of the benefit-risk ratio, especially at the vicinity of eloquent cortical areas.
Conclusion
SEEG-guided RFTC seems to be a safe and effective procedure that merits being considered at the end of an SEEG study, especially in patients in whom resective surgery appears too risky or is contraindicated. The presence of a lesion on MRI, and to a lesser degree the identification of SCIEDs even in the absence of any MRI lesion, were the only two predictors of favorable post-RTFC outcome in our series of particularly complex and severe cases.
